News Virbac

Stocks

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris 11:55:00 2026-09-15 EDT			5-day change	1st Jan Change
315.00 ^EUR	+0.16%		-0.32%	-11.89%

08-20	Cancer vaccines finally garner the spotlight
07-29	Virbac, without the alibi

All News

Mentions Relevance

07-29	Virbac, without the alibi
07-21	Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3
07-20	Virbac, solid performance, targets the top end of its annual guidance range
07-20	Virbac : 2026 second quarter consolidated sales	PU
07-20	Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms	GL
06-19	IBM Renews Its Partnership With France's Virbac
06-16	Rumors Swirl Regarding Potential Merger Between Virbac and Ceva Sante
05-27	Governance: regional reorganization to foster proximity	PU
05-11	Virbac continues decline despite positive recommendation
05-05	Virbac : Step into the Daily Life of an Iberian Pig Farm Manager	PU
04-27	Virbac : Public release of Virbac Annual Report at 31 December 2025.	GL
04-17	Virbac: 2026 starts on strong footing
04-17	Swine health: Virbac signs agreement with MACSO	PU
04-17	Virbac delivers a healthy start to the year
04-16	Virbac SA Reports Consolidated Unaudited Revenue Results for the First Quarter of 2026	CI
04-16	Virbac in fine form despite currency headwinds
04-16	Virbac Q1 revenue EUR 384 mln, maintains 2026 guidance	RE
04-16	Virbac : 2026 first quarter consolidated sales	PU
04-16	Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms	GL
04-07	Virbac : Meet Lucy, a dedicated farm animals vet in Ireland	PU
03-19	Stifel sees Virbac as undervalued, sets 440 euro price target
03-18	Virbac SA, 2025 Earnings Call, Mar 18, 2026
03-18	Virbac in the green following results and outlook
03-18	Virbac : 2025 full-year results	PU
03-18	Virbac